我們已在上線! 進一步了解
RMTI圖示

Rockwell Medical

7.43 USD
-0.55
6.89%
收盤時 已更新 10月16日 下午4:00 EDT
1天
-6.89%
5天
-5.47%
1個月
-4.74%
3個月
29.67%
6個月
-18.89%
今年迄今
-13.9%
1年
-37.56%
5年
-88.04%
10年
-98.82%
 

關於: Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

員工: 157

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 77.8%
負面 22.2%
中性
Business Wire
昨天
Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the third quarter ended September 30, 2026 on Thursday, November 12, 2026.
Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026
中性
Business Wire
前天
Rockwell Medical to Exhibit at ASN Kidney Week 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Come visit Rockwell Medical in Booth #1049 at ASN Kidney Week 2026 at the Colorado Convention Center in Denver, CO.
Rockwell Medical to Exhibit at ASN Kidney Week 2026
中性
Business Wire
9 天前
Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' List
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--This marks the 3rd consecutive year that Rockwell Medical earned this recognition—climbing the ranks from #50 (2024) and #40 (2025) to #16 (2026).
Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' List
中性
Seeking Alpha
2 個月前
Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript
負面
Zacks Investment Research
2 個月前
Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
Rockwell Medical (RMTI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.5 per share a year ago.
Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
中性
Business Wire
2 個月前
Rockwell Medical Announces Second Quarter 2026 Results
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q2'26 results, delivering strong year-over-year growth, expanding gross margin and generating positive operating cash flow.
Rockwell Medical Announces Second Quarter 2026 Results
負面
Zacks Investment Research
2 個月前
Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
中性
Business Wire
2 個月前
Rockwell Medical Advances Quality and Regulatory Leadership
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Brian Cox joins Rockwell Medical as VP, Quality and Regulatory Compliance, bringing more than 20 years' healthcare experience to the Company.
Rockwell Medical Advances Quality and Regulatory Leadership
中性
Business Wire
2 個月前
Rockwell Medical Regains Compliance with Nasdaq Listing Requirements
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical received notice from Nasdaq that it regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).
Rockwell Medical Regains Compliance with Nasdaq Listing Requirements
中性
Business Wire
3 個月前
Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026.
Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026
價格圖表採用Lightweight Charts™實作